(Q39774066)

14 September 2017

title

Synergistic anti-cancer activity by the combination of TRAIL/APO-2L and celastrol (English)

1 reference

14 September 2017

Hong Zhu

1

1 reference

14 September 2017

Wan-Jing Ding

2

1 reference

14 September 2017

Rui Wu

3

1 reference

14 September 2017

Qin-Jie Weng

4

1 reference

14 September 2017

Jian-Shu Lou

5

1 reference

14 September 2017

Rong-Jia Jin

6

1 reference

14 September 2017

Wei Lu

7

1 reference

14 September 2017

Bo Yang

8

1 reference

14 September 2017

Qiao-Jun He

9

1 reference

14 September 2017

language of work or name

1 reference

1 January 2010

1 reference

14 September 2017

1 reference

14 September 2017

volume

28

1 reference

14 September 2017

issue

1

1 reference

14 September 2017

page(s)

23-32

1 reference

Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07357900903095664

A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903095664

Mechanisms of resistance of normal cells to TRAIL induced apoptosis vary between different cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903095664

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903095664

The receptor for the cytotoxic ligand TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903095664

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903095664

TRAIL and apoptosis induction by TNF-family death receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903095664

Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903095664

S-phase checkpoints regulate Apo2 ligand/TRAIL and CPT-11-induced apoptosis of prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903095664

Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903095664

Potent antitumor activity of 10-methoxy-9-nitrocamptothecin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903095664

SH-7, a new synthesized shikonin derivative, exerting its potent antitumor activities as a topoisomerase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903095664

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903095664

Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903095664

Mitochondria-dependent and -independent mechanisms in tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis are both regulated by interferon-gamma in human breast tumour cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903095664

TRAIL cleaves caspase-8, -9 and -3 of AM-1 cells: a possible pathway for TRAIL to induce apoptosis in ameloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903095664

Death receptors: signaling and modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903095664

Insights into cancer therapeutic design based on p53 and TRAIL receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903095664

Safety and antitumor activity of recombinant soluble Apo2 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903095664

TRAIL inactivates the mitotic checkpoint and potentiates death induced by microtubule-targeting agents in human cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903095664

Mechanisms involved in development of resistance to adenovirus-mediated proapoptotic gene therapy in DLD1 human colon cancer cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903095664

Apoptosis Induction in HL-60 Cells and Inhibition of Topoisomerase II by Triterpene Celastrol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903095664

Targeting death and decoy receptors of the tumour-necrosis factor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903095664

Evaluation of combination chemotherapy: integration of nonlinear regression, curve shift, isobologram, and combination index analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903095664

10.3109/07357900903095664

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference